The potential for repositioning antithyroid agents as antiasthma drugs

Affiliations

• ¹ Division of Medical Biochemistry, Saga Medical School, Saga, Japan.
• ² Department of Laboratory Medicine, Saga Medical School, Saga, Japan.
• ³ Division of Pulmonary Medicine, Allergy, and Rheumatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Morioka, Japan.
• ⁴ Department of Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University School of Medicine, Mibu, Japan.
• ⁵ Division of Pulmonary Medicine, Mayo Clinic Arizona, Scottsdale, Ariz.
• ⁶ Graduate School of Nanobioscience, Yokohama City University, Yokohama, Japan.
• ⁷ Department of Biomedical Science, Graduate School of Agricultural and Life Sciences, the University of Tokyo, Tokyo, Japan; Center for Experimental Medicine and Systems Biology, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan.
• ⁸ Center for Experimental Medicine and Systems Biology, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan; Research Institute for Biomedical Sciences, Tokyo University of Science, Noda, Japan.
• ⁹ Division of Immunology, Department of Biomolecular Sciences, Saga Medical School, Saga, Japan.
• ¹⁰ Division of Medical Biochemistry, Saga Medical School, Saga, Japan. Electronic address: kizuhara@cc.saga-u.ac.jp.